January 7, 2025: Francis Medical raises record $80M in Series C to fund its VAPOR 2 study and U.S. launch of Vanquish, its proprietary prostate cancer treatment.
CAUTION: Investigational device. Limited by United States law to investigational use.
7351 Kirkwood Lane N., Suite 130, Maple Grove, MN 55369
Phone: 763-951-0370
Email: info@francismedical.com
Developing novel, disruptive therapeutic solutions to treat prostate, kidney and bladder cancer.
© Copyright Francis Medical, Inc. 2025 | ALL RIGHTS RESERVED | 4206-001_04